Articles by Zack Anchors

Grant will provide support for GLP toxicology studies, preparations for clinical trials and a Phase 1 study

A group effort on lung disease leads to new biological network model

Company plans to leverage database for synthetic, medicinal chemistry research

Dalazatide found to suppress cytokines associated with lupus nephritis in children and teens

Ubiquitin modification plays key roles in homeostasis, cell signaling

Study illuminates link between myocardial fibrosis and obstructive sleep apnea

Catalyst inches closer to FDA approval for Firdapse

Paratek makes headway towards new broad-spectrum antibiotic

Antibody Registry project gains momentum, new commercial partners

PhoreMost and Wistar seek to de-orphan new targets in oncology, aging and immunology

Study suggests Phase 2 Alzheimer’s drug could treat rare Rett syndrome

Recent developments may allow for chronic traumatic encephalopathy to be tested in live humans

Second such expansion since last year driven in part by demand for API services

Prominent role of arrays in company’s overall portfolio recently has focused it more on biobank segment

Bio-Rad and Illumina partner on single-cell genomics solution